X. Liem

Publications by Year

Research Areas

Head and Neck Cancer Studies, Advanced Radiotherapy Techniques, Radiopharmaceutical Chemistry and Applications, Oral health in cancer treatment, Lung Cancer Research Studies

Most-Cited Works

• → Radiomics strategies for risk assessment of tumour failure in head-and-neck cancer(2017)536 cited
• → Pembrolizumab versus cetuximab concurrent with radiotherapy in patients with locally advanced squamous cell carcinoma of head and neck unfit for cisplatin (GORTEC 2015-01 PembroRad): a multicenter, randomized, phase II trial(2022)168 cited
• → Avelumab–cetuximab–radiotherapy versus standards of care in locally advanced squamous-cell carcinoma of the head and neck: The safety phase of a randomised phase III trial GORTEC 2017-01 (REACH)(2020)92 cited
• → LBA35 Avelumab-cetuximab-radiotherapy versus standards of care in patients with locally advanced squamous cell carcinoma of head and neck (LA-SCCHN): Randomized phase III GORTEC-REACH trial(2021)78 cited
• → Phase I dose-escalation study of NBTXR3 activated by intensity-modulated radiation therapy in elderly patients with locally advanced squamous cell carcinoma of the oral cavity or oropharynx(2021)67 cited
• → Weekly Adaptive Radiotherapy vs Standard Intensity-Modulated Radiotherapy for Improving Salivary Function in Patients With Head and Neck Cancer(2023)64 cited
• → LBA38 Pembrolizumab versus cetuximab, concomitant with radiotherapy (RT) in locally advanced head and neck squamous cell carcinoma (LA-HNSCC): Results of the GORTEC 2015-01 “PembroRad” randomized trial(2020)63 cited
• → A phase II randomized trial of pembrolizumab versus cetuximab, concomitant with radiotherapy (RT) in locally advanced (LA) squamous cell carcinoma of the head and neck (SCCHN): First results of the GORTEC 2015-01 “PembroRad” trial.(2018)53 cited
• → A Practical Approach to the Management of Radiation-Induced Hemorrhagic Cystitis(2015)46 cited
• → Helical Tomotherapy for Inoperable Breast Cancer: A New Promising Tool(2013)27 cited